Anthony S. Wierzbicki’s publications

2. Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation. Watts GF, Gidding S, Wierzbicki AS, Toth PP, Alonso R, Brown WV, Bruckert E, Defesche J, Lin KK, Livingston M, Mata P, Parhofer KG, Raal FJ, Santos RD, Sijbrands EJ, Simpson WG, Sullivan DR, Susekov AV, Tomlinson B, Wiegman A, Yamashita S, Kastelein JJ. J Clin Lipidol. 2014 March - April;8(2):148-172. doi: 10.1016/j.jacl.2014.01.002. Epub 2014 Jan 16. Review. PMID: 24636175 [PubMed - as supplied by publisher] 3. Lipid-lowering drug therapies and chronic obstructive pulmonary disease: lung failure or just heart failure? Wierzbicki AS, Louis R. Int J Clin Pract. 2014 Feb;68(2):144-51. doi: 10.1111/ijcp.12329. No abstract available. PMID: 24460612 [PubMed - in process] 4. Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation. Watts GF, Gidding S, Wierzbicki AS, Toth PP, Alonso R, Brown WV, Bruckert E, Defesche J, Lin KK, Livingston M, Mata P, Parhofer KG, Raal FJ, Santos RD, Sijbrands EJ, Simpson WG, Sullivan DR, Susekov AV, Tomlinson B, Wiegman A, Yamashita S, Kastelein JJ. Int J Cardiol. 2014 Feb 15;171(3):309-25. doi: 10.1016/j.ijcard.2013.11.025. Epub 2013 Nov 20. PMID: 24418289 [PubMed - in process] 5. A cross-sectional randomised study of fracture risk in people with HIV infection in the probono 1 study. Peters BS, Perry M, Wierzbicki AS, Wolber LE, Blake GM, Patel N, Hoile R, Duncan A, Kulasegaram R, Williams FM. PLoS One. 2013 Oct 29;8(10):e78048. doi: 10.1371/journal.pone.0078048. eCollection 2013. PMID: 24205086 [PubMed - in process] Free PMC Article 6. Statin-fibrate combination therapy is safe and effective in normalizing lipid profile and in keeping cardiovascular event rates low. Athyros VG, Wierzbicki AS. Curr Med Res Opin. 2014 Jan;30(1):57-8. doi: 10.1185/03007995.2013.856287. Epub 2013 Oct 25. No abstract available. PMID: 24160920 [PubMed - in process] 7. CDKN2B expression in adipose tissue of familial combined hyperlipidemia patients. Horswell SD, Fryer LG, Hutchison CE, Zindrou D, Speedy HE, Town MM, Duncan EJ, Sivapackianathan R, Patel HN, Jones EL, Braithwaite A, Salm MP, Neuwirth CK, Potter E, Anderson JR, Taylor KM, Seed M, Betteridge DJ, Crook MA, Wierzbicki AS, Scott J, Naoumova RP, Shoulders CC. J Lipid Res. 2013 Dec;54(12):3491-505. doi: 10.1194/jlr.M041814. Epub 2013 Oct 8. PMID: 24103848 [PubMed - in process]

8. Lower, faster, better: the delusions of surrogate markers in hypertension. 1 of 37 Wierzbicki AS, Ferro A. Int J Clin Pract. 2013 Sep;67(9):822-4. doi: 10.1111/ijcp.12185. No abstract available. PMID: 23952461 [PubMed - indexed for MEDLINE] Related citations 9. The need for combination drug therapies in patients with complex dyslipidemia. Barnett J, Viljoen A, Wierzbicki AS. Curr Cardiol Rep. 2013 Aug;15(8):391. doi: 10.1007/s11886-013-0391-1. Review. PMID: 23812840 [PubMed - indexed for MEDLINE] Related citations 10. Lipid-lowering agents. Ewang-Emukowhate M, Wierzbicki AS. J Cardiovasc Pharmacol Ther. 2013 Sep;18(5):401-11. doi: 10.1177/1074248413492906. Epub 2013 Jun 27. PMID: 23811423 [PubMed - in process] Related citations 11. All at sea: new lipid-lowering drug trials continue to disappoint. Wierzbicki AS. Int J Clin Pract. 2013 Jul;67(7):595-8. doi: 10.1111/ijcp.12126. No abstract available. PMID: 23758438 [PubMed - indexed for MEDLINE] Related citations 12. New therapies to reduce low-density lipoprotein cholesterol. Wierzbicki AS, Viljoen A, Hardman TC, Mikhailidis DP. Curr Opin Cardiol. 2013 Jul;28(4):452-7. doi: 10.1097/HCO.0b013e3283605fa2. Review. PMID: 23736819 [PubMed - indexed for MEDLINE] Related citations 13. Epicardial fat and vascular risk: a narrative review. Katsiki N, Mikhailidis DP, Wierzbicki AS. Curr Opin Cardiol. 2013 Jul;28(4):458-63. doi: 10.1097/HCO.0b013e3283605fba. Review. PMID: 23591557 [PubMed - indexed for MEDLINE] Related citations 14. Secondary tests for stratification of risk for atherosclerosis. Wierzbicki AS, Reynolds TM. Curr Med Res Opin. 2013 Jun;29(6):597-9. doi: 10.1185/03007995.2013.794133. Epub 2013 Apr 18. No abstract available. PMID: 23574149 [PubMed - indexed for MEDLINE] Related citations 15. Doubling up: maximising statin therapy as opposed to adding other drugs for cardiovascular disease prevention. Wierzbicki AS. Int J Clin Pract. 2013 May;67(5):391-3. doi: 10.1111/ijcp.12102. No abstract available. PMID: 23574098 [PubMed - indexed for MEDLINE] Related citations 16. Dyslipidaemia: Failure to THRIVE: the end for niacin? Wierzbicki AS. Nat Rev Cardiol. 2013 May;10(5):246-7. doi: 10.1038/nrcardio.2013.48. Epub 2013 Apr 2. No abstract available. PMID: 23546446 [PubMed - indexed for MEDLINE]

2 of 37 Related citations 17. Sugar, sugar. Wierzbicki AS. Int J Clin Pract. 2013 Apr;67(4):294-6. doi: 10.1111/ijcp.12072. No abstract available. PMID: 23521321 [PubMed - indexed for MEDLINE] Related citations 18. Effectiveness of alternative strategies to define index case phenotypes to aid genetic diagnosis of familial hypercholesterolaemia. Clarke RE, Padayachee ST, Preston R, McMahon Z, Gordon M, Graham C, Crook MA, Wierzbicki AS. Heart. 2013 Feb;99(3):175-80. doi: 10.1136/heartjnl-2012-302917. Epub 2012 Dec 4. PMID: 23213176 [PubMed - indexed for MEDLINE] Related citations 19. Screening for chronic comorbid diseases in people with HIV: the need for a strategic approach. Peters B, Post F, Wierzbicki AS, Phillips A, Power L, Das S, Johnson M, Moyle G, Hughes L, Wilkins E, McCloskey E, Compston J, Di Angelantonio E. HIV Med. 2013 Jan;14 Suppl 1:1-11. doi: 10.1111/j.1468-1293.2012.01055.x. Review. PMID: 23121515 [PubMed - indexed for MEDLINE] Related citations 20. Alipogene tiparvovec: gene therapy for lipoprotein lipase deficiency. Wierzbicki AS, Viljoen A. Expert Opin Biol Ther. 2013 Jan;13(1):7-10. doi: 10.1517/14712598.2013.738663. Epub 2012 Nov 6. PMID: 23126631 [PubMed - indexed for MEDLINE] Related citations 21. U.K. consensus statement on safe clinical prescribing of bexarotene for patients with cutaneous T- cell lymphoma. Scarisbrick JJ, Morris S, Azurdia R, Illidge T, Parry E, Graham-Brown R, Cowan R, Gallop-Evans E, Wachsmuth R, Eagle M, Wierzbicki AS, Soran H, Whittaker S, Wain EM. Br J Dermatol. 2013 Jan;168(1):192-200. doi: 10.1111/bjd.12042. Epub 2012 Dec 3. PMID: 22963233 [PubMed - indexed for MEDLINE] Related citations 22. New directions in cardiovascular risk assessment: the role of secondary risk stratification markers. Wierzbicki AS. Int J Clin Pract. 2012 Jul;66(7):622-30. doi: 10.1111/j.1742-1241.2012.02956.x. Review. PMID: 22698414 [PubMed - indexed for MEDLINE] Related citations 23. Nonalcoholic fatty liver disease and lipids. Wierzbicki AS, Oben J. Curr Opin Lipidol. 2012 Aug;23(4):345-52. doi: 10.1097/MOL.0b013e3283541cfc. Review. PMID: 22617751 [PubMed - indexed for MEDLINE] Related citations 24. Lumping and splitting in cardiovascular risk. Wierzbicki AS. Int J Clin Pract. 2012 Jun;66(6):522-4. doi: 10.1111/j.1742-1241.2012.02949.x. No abstract available. PMID: 22607501 [PubMed - indexed for MEDLINE] Related citations

3 of 37 25. Triglycerides: a case for treatment? Wierzbicki AS, Clarke RE, Viljoen A, Mikhailidis DP. Curr Opin Cardiol. 2012 Jul;27(4):398-404. doi: 10.1097/HCO.0b013e328353adc1. Review. PMID: 22565137 [PubMed - indexed for MEDLINE] Related citations 26. Statins and noncardiac vascular disease. Paraskevas KI, Wierzbicki AS, Mikhailidis DP. Curr Opin Cardiol. 2012 Jul;27(4):392-7. doi: 10.1097/HCO.0b013e328353add9. Review. PMID: 22525327 [PubMed - indexed for MEDLINE] Related citations 27. Inhibition of pro-protein convertase subtilisin kexin 9 [corrected] (PCSK-9) as a treatment for hyperlipidaemia. Wierzbicki AS, Hardman TC, Viljoen A. Expert Opin Investig Drugs. 2012 May;21(5):667-76. doi: 10.1517/13543784.2012.679340. Review. Erratum in: Expert Opin Investig Drugs. 2012 Aug;21(8):1241. PMID: 22493980 [PubMed - indexed for MEDLINE] Related citations 28. Diagnosis and treatment of severe hypertriglyceridemia. Viljoen A, Wierzbicki AS. Expert Rev Cardiovasc Ther. 2012 Apr;10(4):505-14. doi: 10.1586/erc.12.21. Review. PMID: 22458582 [PubMed - indexed for MEDLINE] Related citations 29. The origin, global distribution, and functional impact of the human 8p23 inversion polymorphism. Salm MP, Horswell SD, Hutchison CE, Speedy HE, Yang X, Liang L, Schadt EE, Cookson WO, Wierzbicki AS, Naoumova RP, Shoulders CC. Genome Res. 2012 Jun;22(6):1144-53. doi: 10.1101/gr.126037.111. Epub 2012 Mar 7. PMID: 22399572 [PubMed - indexed for MEDLINE] Free PMC Article Related citations 30. New lipid-lowering drugs: an update. Wierzbicki AS, Hardman TC, Viljoen A. Int J Clin Pract. 2012 Mar;66(3):270-80. doi: 10.1111/j.1742-1241.2011.02867.x. Review. PMID: 22340447 [PubMed - indexed for MEDLINE] Related citations 31.

Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients: an observational

study. Meek C, Wierzbicki AS, Jewkes C, Twomey PJ, Crook MA, Jones A, Viljoen A. Curr Med Res Opin. 2012 Mar;28(3):371-8. doi: 10.1185/03007995.2012.657302. Epub 2012 Feb 7. PMID: 22256801 [PubMed - indexed for MEDLINE] Related citations 32. The effect of a 12-week course of omega-3 polyunsaturated fatty acids on lipid parameters in hypertriglyceridemic adult HIV-infected patients undergoing HAART: a randomized, placebo- controlled pilot trial. Peters BS, Wierzbicki AS, Moyle G, Nair D, Brockmeyer N.

4 of 37 Clin Ther. 2012 Jan;34(1):67-76. doi: 10.1016/j.clinthera.2011.12.001. Epub 2011 Dec 31. PMID: 22212377 [PubMed - indexed for MEDLINE] Related citations 33. HDL: who needs it? Wierzbicki AS. Int J Clin Pract. 2011 Nov;65(11):1111-3. doi: 10.1111/j.1742-1241.2011.02769.x. No abstract available. PMID: 21995687 [PubMed - indexed for MEDLINE] Related citations 34. The ezetimibe Jonah: the trials and tribulations of an unlucky drug. Wierzbicki AS. Int J Clin Pract. 2011 Dec;65(12):1207-8. doi: 10.1111/j.1742-1241.2011.02789.x. Epub 2011 Sep 26. No abstract available. PMID: 21951808 [PubMed - indexed for MEDLINE] Related citations 35. Investigating mixed hyperlipidaemia. Viljoen A, Wierzbicki AS. BMJ. 2011 Aug 25;343:d5146. doi: 10.1136/bmj.d5146. No abstract available. PMID: 21868456 [PubMed - indexed for MEDLINE] Related citations 36. A renaissance for cardio-metabolic surgery: better outcomes and lower costs? Wierzbicki AS, Hubbard JG, Botha AJ. Int J Clin Pract. 2011 Jul;65(7):728-32. doi: 10.1111/j.1742-1241.2011.02696.x. No abstract available. PMID: 21676116 [PubMed - indexed for MEDLINE] Related citations 37. "European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses: executive summary. Mikhailidis DP, Elisaf M, Rizzo M, Berneis K, Griffin B, Zambon A, Athyros V, de Graaf J, März W, Parhofer KG, Rini GB, Spinas GA, Tomkin GH, Tselepis AD, Wierzbicki AS, Winkler K, Florentin M, Liberopoulos E. Curr Vasc Pharmacol. 2011 Sep;9(5):531-2. No abstract available. PMID: 21595629 [PubMed - indexed for MEDLINE] Related citations 38. "European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses. Mikhailidis DP, Elisaf M, Rizzo M, Berneis K, Griffin B, Zambon A, Athyros V, de Graaf J, März W, Parhofer KG, Rini GB, Spinas GA, Tomkin GH, Tselepis AD, Wierzbicki AS, Winkler K, Florentin M, Liberopoulos E. Curr Vasc Pharmacol. 2011 Sep;9(5):533-71. PMID: 21595628 [PubMed - indexed for MEDLINE] Related citations 39. Rimonabant improves cholesterol, insulin resistance and markers of non-alcoholic fatty liver in morbidly obese patients: a retrospective cohort study. Wierzbicki AS, Pendleton S, McMahon Z, Dar A, Oben J, Crook MA, Botha AJ. Int J Clin Pract. 2011 Jun;65(6):713-5. doi: 10.1111/j.1742-1241.2011.02683.x. No abstract available.

5 of 37 PMID: 21564446 [PubMed - indexed for MEDLINE] Related citations 40. Pulmonary arterial hypertension and statins: an update. Katsiki N, Wierzbicki AS, Mikhailidis DP. Curr Opin Cardiol. 2011 Jul;26(4):322-6. doi: 10.1097/HCO.0b013e32834659bf. Review. PMID: 21478744 [PubMed - indexed for MEDLINE] Related citations 41. Ideal lipid profile and genes for an extended life span. Kolovou G, Kolovou V, Vasiliadis I, Wierzbicki AS, Mikhailidis DP. Curr Opin Cardiol. 2011 Jul;26(4):348-55. doi: 10.1097/HCO.0b013e32834659d4. Review. PMID: 21478743 [PubMed - indexed for MEDLINE] Related citations 42. Prescribing high-dose lipid-lowering therapy early to avoid subsequent cardiovascular events: is this a cost-effective strategy? Ara R, Pandor A, Stevens J, Rafia R, Ward SE, Rees A, Durrington PN, Reynolds TM, Wierzbicki AS, Stevenson M. Eur J Prev Cardiol. 2012 Jun;19(3):474-83. doi: 10.1177/1741826711406616. Epub 2011 Apr 1. PMID: 21460076 [PubMed - indexed for MEDLINE] Related citations 43. New lipid modulating drugs: the role of microsomal transport protein inhibitors. Rizzo M, Wierzbicki AS. Curr Pharm Des. 2011;17(9):943-9. Review. PMID: 21418029 [PubMed - indexed for MEDLINE] Related citations 44. Niacin: the only vitamin that reduces cardiovascular events. Wierzbicki AS. Int J Clin Pract. 2011 Apr;65(4):379-85. doi: 10.1111/j.1742-1241.2011.02630.x. No abstract available. PMID: 21401825 [PubMed - indexed for MEDLINE] Related citations 45. NO problem: arterial and venous endothelial function and erectile dysfunction. Wierzbicki AS, Jackson G. Eur Urol. 2011 Jun;59(6):956-8. doi: 10.1016/j.eururo.2011.02.019. Epub 2011 Feb 18. No abstract available. PMID: 21333436 [PubMed - indexed for MEDLINE] Related citations 46. Association of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD). Manghat P, Souleimanova I, Cheung J, Wierzbicki AS, Harrington DJ, Shearer MJ, Chowienczyk P, Fogelman I, Nerlander M, Goldsmith D, Hampson G. Bone. 2011 May 1;48(5):1127-32. doi: 10.1016/j.bone.2011.01.016. Epub 2011 Jan 31. Erratum in: Bone. 2011 Sep;49(3):588. Nerlander, M [removed]; Chowiencki, P [corrected to Chowienczyk, P]. Bone. 2013 Mar;53(1):319. Nerlander, M [added]. PMID: 21281749 [PubMed - indexed for MEDLINE] Related citations 47. Statin wars: efficacy vs. cost. Wierzbicki AS.

6 of 37 Int J Clin Pract. 2011 Feb;65(2):108-11. doi: 10.1111/j.1742-1241.2010.02586.x. No abstract available. PMID: 21235691 [PubMed - indexed for MEDLINE] Related citations 48. Cardiovascular disease and the seeds of innovation: a call for papers. Wierzbicki AS. Int J Clin Pract. 2011 Feb;65(2):107-8. doi: 10.1111/j.1742-1241.2010.02614.x. No abstract available. PMID: 21235690 [PubMed - indexed for MEDLINE] Related citations 49. Gender-based cardiometabolic risk evaluation in minority and non-minority men grading the evidence of non-traditional determinants of cardiovascular risk. Billups KL, Miner MM, Wierzbicki AS, Jackson G. Int J Clin Pract. 2011 Feb;65(2):134-47. doi: 10.1111/j.1742-1241.2010.02564.x. Epub 2010 Dec 29. Review. PMID: 21199197 [PubMed - indexed for MEDLINE] Related citations 50. Getting better value from the NHS drug budget. Moon JC, Flett AS, Godman BB, Grosso AM, Wierzbicki AS. BMJ. 2010 Dec 17;341:c6449. doi: 10.1136/bmj.c6449. No abstract available. PMID: 21169320 [PubMed - indexed for MEDLINE] Related citations 51. Cardiovascular screening: which populations, what measures of risk? Wierzbicki AS. Int J Clin Pract. 2011 Jan;65(1):3-5. doi: 10.1111/j.1742-1241.2010.02566.x. No abstract available. PMID: 21155938 [PubMed - indexed for MEDLINE] Related citations 52. Sodium-glucose co-transporter 2 inhibitors: from apple tree to 'Sweet Pee'. Hardman TC, Rutherford P, Dubrey SW, Wierzbicki AS. Curr Pharm Des. 2010;16(34):3830-8. Review. PMID: 21128897 [PubMed - indexed for MEDLINE] Related citations 53. The assessment of metabolic syndrome in UK patients with HIV using two different definitions: CREATE 2 study. Elgalib A, Aboud M, Kulasegaram R, Dimian C, Duncan A, Wierzbicki AS, Peters BS. Curr Med Res Opin. 2011 Jan;27(1):63-9. doi: 10.1185/03007995.2010.537212. Epub 2010 Nov 22. PMID: 21091096 [PubMed - indexed for MEDLINE] Related citations 54. Adult Refsum disease: a form of tapetoretinal dystrophy accessible to therapy. Rüether K, Baldwin E, Casteels M, Feher MD, Horn M, Kuranoff S, Leroy BP, Wanders RJ, Wierzbicki AS. Surv Ophthalmol. 2010 Nov-Dec;55(6):531-8. doi: 10.1016/j.survophthal.2010.03.007. Epub 2010 Sep 20. Review. PMID: 20850855 [PubMed - indexed for MEDLINE] Related citations 55. Comparing apples and pears: assessment of lipid-lowering therapies differentiated by side effects. Wierzbicki AS.

7 of 37 Int J Clin Pract. 2010 Sep;64(10):1324-6. doi: 10.1111/j.1742-1241.2010.02460.x. No abstract available. PMID: 20716135 [PubMed - indexed for MEDLINE] Related citations 56. The incidence of low eGFR and proteinuria in a large tertiary referral lipid clinic. Davies JB, Crook MA, Wierzbicki AS, Goldsmith DJ. Int Urol Nephrol. 2011 Sep;43(3):821-5. doi: 10.1007/s11255-010-9819-3. Epub 2010 Aug 13. PMID: 20706786 [PubMed - indexed for MEDLINE] Related citations 57. The effect of fibrate-statin combination therapy on cardiovascular events: a retrospective cohort analysis. Wierzbicki AS, Morrell J, Hemsley D, McMahon Z, Crook MA, Wray R. Curr Med Res Opin. 2010 Sep;26(9):2141-6. doi: 10.1185/03007995.2010.503429. PMID: 20662558 [PubMed - indexed for MEDLINE] Related citations 58. Cardiovascular risk evaluation and antiretroviral therapy effects in an HIV cohort: implications for clinical management: the CREATE 1 study. Aboud M, Elgalib A, Pomeroy L, Panayiotakopoulos G, Skopelitis E, Kulasegaram R, Dimian C, C Lampe F, Duncan A, Wierzbicki AS, Peters BS. Int J Clin Pract. 2010 Aug;64(9):1252-9. doi: 10.1111/j.1742-1241.2010.02424.x. PMID: 20653801 [PubMed - indexed for MEDLINE] Free PMC Article Related citations 59. The poly-pill: does it work and is chronic therapy acceptable? Wierzbicki AS, Minhas R. Int J Clin Pract. 2010 Aug;64(9):1171-3. doi: 10.1111/j.1742-1241.2010.02476.x. No abstract available. PMID: 20653793 [PubMed - indexed for MEDLINE] Related citations 60. Practice makes perfect: reflections on a primary care treatment-to-target study. Wierzbicki AS. Int J Clin Pract. 2010 Jul;64(8):1006-8. doi: 10.1111/j.1742-1241.2010.02459.x. No abstract available. PMID: 20642700 [PubMed - indexed for MEDLINE] Related citations 61. Fibrates: no ACCORD on their use in the treatment of dyslipidaemia. Wierzbicki AS. Curr Opin Lipidol. 2010 Aug;21(4):352-8. doi: 10.1097/MOL.0b013e32833c1e74. Review. PMID: 20625256 [PubMed - indexed for MEDLINE] Related citations 62. The effectiveness of long-term dietary therapy in the treatment of adult Refsum disease. Baldwin EJ, Gibberd FB, Harley C, Sidey MC, Feher MD, Wierzbicki AS. J Neurol Neurosurg Psychiatry. 2010 Sep;81(9):954-7. doi: 10.1136/jnnp.2008.161059. Epub 2010 Jun 14. PMID: 20547622 [PubMed - indexed for MEDLINE] Related citations 63. Putting protection first: vascular risk assessment in atypical populations. Wierzbicki AS, Peters BS.

8 of 37 Int J Clin Pract. 2010 May;64(6):664-6. doi: 10.1111/j.1742-1241.2009.02334.x. No abstract available. PMID: 20518943 [PubMed - indexed for MEDLINE] Related citations 64. Aortic stenosis and lipids: does intervention work? Wierzbicki AS, Viljoen A, Chambers JB. Curr Opin Cardiol. 2010 Jul;25(4):379-84. doi: 10.1097/HCO.0b013e3283393c9b. Review. PMID: 20414108 [PubMed - indexed for MEDLINE] Related citations 65. Aggressive statin treatment, very low serum cholesterol levels and haemorrhagic stroke: is there an association? Athyros VG, Tziomalos K, Karagiannis A, Wierzbicki AS, Mikhailidis DP. Curr Opin Cardiol. 2010 Jul;25(4):406-10. doi: 10.1097/HCO.0b013e3283393c1a. Review. PMID: 20375883 [PubMed - indexed for MEDLINE] Related citations 66. Hyperlipidaemia in paediatric patients: the role of lipid-lowering therapy in clinical practice. Wierzbicki AS, Viljoen A. Drug Saf. 2010 Feb 1;33(2):115-25. doi: 10.2165/11319490-000000000-00000. Review. PMID: 20082538 [PubMed - indexed for MEDLINE] Related citations 67. Safety and efficacy of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia. Viljoen A, Wierzbicki AS. Drug Healthc Patient Saf. 2010;2:61-71. Epub 2010 May 24. PMID: 21701618 [PubMed] Free PMC Article Related citations 68. Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease. Manghat P, Fraser WD, Wierzbicki AS, Fogelman I, Goldsmith DJ, Hampson G. Osteoporos Int. 2010 Nov;21(11):1853-61. doi: 10.1007/s00198-009-1142-4. Epub 2009 Dec 9. PMID: 20012018 [PubMed - indexed for MEDLINE] Related citations 69. Towards companion diagnostics for the management of statin therapy. Viljoen A, Wierzbicki AS. Expert Opin Med Diagn. 2009 Nov;3(6):659-71. doi: 10.1517/17530050903222254. Epub 2009 Aug 27. PMID: 23496050 [PubMed] Related citations 70. Hot and bothered: C-reactive protein, inflammation and atherosclerosis. Wierzbicki AS. Int J Clin Pract. 2009 Nov;63(11):1550-3. doi: 10.1111/j.1742-1241.2009.02211.x. No abstract available. PMID: 19832810 [PubMed - indexed for MEDLINE] Related citations 71. Are intensive lipid-lowering regimens an optimal economic strategy in patients with ACS? An acute and chronic perspective. Ara R, Rafia R, Ward SE, Wierzbicki AS, Reynolds TM, Rees A, Pandor A.

9 of 37 Expert Rev Pharmacoecon Outcomes Res. 2009 Oct;9(5):423-33. doi: 10.1586/erp.09.42. Review. PMID: 19817526 [PubMed - indexed for MEDLINE] Related citations 72. Storms, tea cups and the adverse effects of statins. Wierzbicki AS. Int J Clin Pract. 2009 Sep;63(9):1268-70. doi: 10.1111/j.1742-1241.2009.02113.x. No abstract available. PMID: 19691606 [PubMed - indexed for MEDLINE] Related citations 73. Future challenges for microsomal transport protein inhibitors. Wierzbicki AS, Hardman T, Prince WT. Curr Vasc Pharmacol. 2009 Jul;7(3):277-86. Review. PMID: 19601852 [PubMed - indexed for MEDLINE] Related citations 74. Vascular risk screening: possible or too much, too soon? Wierzbicki AS, Reynolds TM. Int J Clin Pract. 2009 Jul;63(7):989-96. doi: 10.1111/j.1742-1241.2009.02111.x. No abstract available. PMID: 19570116 [PubMed - indexed for MEDLINE] Related citations 75. Truthiness and quality improvement. Minhas R, Wierzbicki AS. Int J Clin Pract. 2009 Jun;63(6):839-40. doi: 10.1111/j.1742-1241.2009.02073.x. No abstract available. PMID: 19490194 [PubMed - indexed for MEDLINE] Related citations 76. Fibrates in the treatment of cardiovascular risk and atherogenic dyslipidaemia. Wierzbicki AS. Curr Opin Cardiol. 2009 Jul;24(4):372-9. doi: 10.1097/HCO.0b013e32832c0b3d. Review. PMID: 19424060 [PubMed - indexed for MEDLINE] Related citations 77. Lipoprotein a: where are we now? Tziomalos K, Athyros VG, Wierzbicki AS, Mikhailidis DP. Curr Opin Cardiol. 2009 Jul;24(4):351-7. doi: 10.1097/HCO.0b013e32832ac21a. Review. PMID: 19417640 [PubMed - indexed for MEDLINE] Related citations 78. Factors regulating circulating vascular endothelial growth factor (VEGF): association with bone mineral density (BMD) in post-menopausal osteoporosis. Costa N, Paramanathan S, Mac Donald D, Wierzbicki AS, Hampson G. Cytokine. 2009 Jun;46(3):376-81. doi: 10.1016/j.cyto.2009.03.012. Epub 2009 Apr 24. PMID: 19394248 [PubMed - indexed for MEDLINE] Related citations 79. SEARCHing for JUPITER: starry-eyed optimism is not warranted. Wierzbicki AS. Int J Clin Pract. 2009 May;63(5):685-8. doi: 10.1111/j.1742-1241.2009.02032.x. No abstract available. PMID: 19392917 [PubMed - indexed for MEDLINE]

10 of 37 Related citations 80. Potential options to treat hypertriglyceridaemia. Viljoen A, Wierzbicki AS. Curr Drug Targets. 2009 Apr;10(4):356-62. Review. PMID: 19355860 [PubMed - indexed for MEDLINE] Related citations 81. Targeting triglycerides in secondary prevention: should we bother? Athyros VG, Kakafika AI, Wierzbicki AS, Karagiannis A, Mikhailidis DP. Int J Clin Pract. 2009 Jan;63(1):15-8. doi: 10.1111/j.1742-1241.2008.01837.x. Review. No abstract available. PMID: 19125988 [PubMed - indexed for MEDLINE] Related citations 82. The copper/caeruloplasmin ratio in routine clinical practice in different laboratories. Twomey PJ, Wierzbicki AS, Reynolds TM, Viljoen A. J Clin Pathol. 2009 Jan;62(1):60-3. doi: 10.1136/jcp.2007.055111. PMID: 19103863 [PubMed - indexed for MEDLINE] Related citations 83. Muddy waters: more stormy SEAS for ezetimibe. Wierzbicki AS. Int J Clin Pract. 2008 Oct;62(10):1470-3. doi: 10.1111/j.1742-1241.2008.01888.x. No abstract available. PMID: 18822020 [PubMed - indexed for MEDLINE] Related citations 84. Familial hypercholesterolaemia: summary of NICE guidance. Wierzbicki AS, Humphries SE, Minhas R; Guideline Development Group. BMJ. 2008 Aug 27;337:a1095. doi: 10.1136/bmj.a1095. No abstract available. PMID: 18753174 [PubMed - indexed for MEDLINE] Related citations 85. A fishy business: omega-3 fatty acids and cardiovascular disease. Wierzbicki AS. Int J Clin Pract. 2008 Aug;62(8):1142-6. doi: 10.1111/j.1742-1241.2008.01781.x. No abstract available. PMID: 18705819 [PubMed - indexed for MEDLINE] Related citations 86. Shielding the population from the metabolic syndrome? There is one born every minute. Wierzbicki AS. Int J Clin Pract. 2008 Aug;62(8):1132-4. doi: 10.1111/j.1742-1241.2008.01790.x. No abstract available. PMID: 18705816 [PubMed - indexed for MEDLINE] Related citations 87. Surrogate markers, atherosclerosis and cardiovascular disease prevention. Wierzbicki AS. Int J Clin Pract. 2008 Jul;62(7):981-7. doi: 10.1111/j.1742-1241.2008.01794.x. Review. No abstract available. PMID: 18564270 [PubMed - indexed for MEDLINE] Related citations 88. Multiple actions of high-density lipoprotein.

11 of 37 Florentin M, Liberopoulos EN, Wierzbicki AS, Mikhailidis DP. Curr Opin Cardiol. 2008 Jul;23(4):370-8. doi: 10.1097/HCO.0b013e3283043806. Review. PMID: 18520722 [PubMed - indexed for MEDLINE] Related citations 89. Lipoproteins: from A to B and maybe C-III. Wierzbicki AS. Int J Clin Pract. 2008 May;62(5):674-6. doi: 10.1111/j.1742-1241.2008.01718.x. No abstract available. PMID: 18412930 [PubMed - indexed for MEDLINE] Related citations 90. Insulin resistance phenotypes and coronary artery disease in a native Pakistani cohort. Wierzbicki AS, Nishtar S, Lumb PJ, Lambert-Hammill M, Crook MA, Marber MS, Gill J. Int J Clin Pract. 2008 May;62(5):701-7. doi: 10.1111/j.1742-1241.2008.01722.x. Epub 2008 Mar 12. PMID: 18341566 [PubMed - indexed for MEDLINE] Related citations 91. Enhanced LDL-C reduction: lower is better. Does it matter how? Viljoen A, Wierzbicki AS. Int J Clin Pract. 2008 Apr;62(4):518-20. doi: 10.1111/j.1742-1241.2008.01721.x. No abstract available. PMID: 18324945 [PubMed - indexed for MEDLINE] Related citations 92. Non-ceruloplasmin-bound copper in routine clinical practice in different laboratories. Twomey PJ, Viljoen A, Reynolds TM, Wierzbicki AS. J Trace Elem Med Biol. 2008;22(1):50-3. doi: 10.1016/j.jtemb.2007.11.001. Epub 2008 Feb 19. PMID: 18319140 [PubMed - indexed for MEDLINE] Related citations 93. Alpha-methylacyl-CoA racemase--an 'obscure' metabolic enzyme takes centre stage. Lloyd MD, Darley DJ, Wierzbicki AS, Threadgill MD. FEBS J. 2008 Mar;275(6):1089-102. doi: 10.1111/j.1742-4658.2008.06290.x. Epub 2008 Feb 12. Review. PMID: 18279392 [PubMed - indexed for MEDLINE] Related citations 94. Epidemiological studies are meaningless without proof of long-term data stability. Reynolds TM, Wierzbicki AS, Twomey PJ. Am J Med. 2008 Feb;121(2):e7; author reply e9-10. doi: 10.1016/j.amjmed.2007.08.040. No abstract available. PMID: 18261489 [PubMed - indexed for MEDLINE] Related citations 95. Familial combined hyperlipidaemia: under - defined and under - diagnosed? Wierzbicki AS, Graham CA, Young IS, Nicholls DP. Curr Vasc Pharmacol. 2008 Jan;6(1):13-22. Review. PMID: 18220935 [PubMed - indexed for MEDLINE] Related citations 96. HIV lipodystrophy and its metabolic consequences: implications for clinical practice. Wierzbicki AS, Purdon SD, Hardman TC, Kulasegaram R, Peters BS. Curr Med Res Opin. 2008 Mar;24(3):609-24. doi: 10.1185/030079908X272742. Review. PMID: 18208641 [PubMed - indexed for MEDLINE]

12 of 37 Related citations 97. The relationship between serum copper and ceruloplasmin in routine clinical practice. Twomey PJ, Reynolds TM, Wierzbicki AS, Viljoen A. Int J Clin Pract. 2008 Mar;62(3):485-7. Epub 2007 Nov 21. PMID: 18031527 [PubMed - indexed for MEDLINE] Related citations 98. Peroxisomal disorders affecting phytanic acid alpha-oxidation: a review. Wierzbicki AS. Biochem Soc Trans. 2007 Nov;35(Pt 5):881-6. Review. PMID: 17956237 [PubMed - indexed for MEDLINE] Related citations 99. Dr Brian Gibberd (1931-2006): a pioneering clinician in Refsum's disease. Wierzbicki AS, Lloyd MD. Biochem Soc Trans. 2007 Nov;35(Pt 5):862-4. PMID: 17956233 [PubMed - indexed for MEDLINE] Related citations 100. Intervening on HDL-C: is it possible? Does it work? Wierzbicki AS. Int J Clin Pract. 2007 Nov;61(11):1782-6. No abstract available. PMID: 17935541 [PubMed - indexed for MEDLINE] Related citations 101. Quality as well as quantity? Beyond low-density lipoprotein-cholesterol - the role of particle size. Wierzbicki AS. Int J Clin Pract. 2007 Nov;61(11):1780-2. No abstract available. PMID: 17935540 [PubMed - indexed for MEDLINE] Related citations 102. The relationship between gonadotrophins, gonadal hormones and bone mass in men. Karim N, MacDonald D, Dolan AL, Fogelman I, Wierzbicki AS, Hampson G. Clin Endocrinol (Oxf). 2008 Jan;68(1):94-101. Epub 2007 Aug 30. PMID: 17760881 [PubMed - indexed for MEDLINE] Related citations 103. Waist circumference, metabolic syndrome and coronary artery disease in a Pakistani cohort. Wierzbicki AS, Nishtar S, Lumb PJ, Lambert-Hammill M, Crook MA, Marber MS, Gill J. Int J Cardiol. 2008 Aug 1;128(1):77-82. Epub 2007 Aug 8. PMID: 17689739 [PubMed - indexed for MEDLINE] Related citations 104. Primary and secondary prevention in obesity. Wierzbicki AS. Int J Clin Pract. 2007 Sep;61(9):1431-4. No abstract available. PMID: 17686089 [PubMed - indexed for MEDLINE] Related citations 105. Homocysteine and cardiovascular disease: a review of the evidence. Wierzbicki AS. Diab Vasc Dis Res. 2007 Jun;4(2):143-50. Review. PMID: 17654449 [PubMed - indexed for MEDLINE] Free Article Related citations 106. Interpreting clinical trials of diabetic dyslipidaemia: new insights.

13 of 37 Wierzbicki AS. Diabetes Obes Metab. 2009 Mar;11(3):261-70. Epub 2007 Jul 21. PMID: 17645560 [PubMed - indexed for MEDLINE] Related citations 107. METEOR: aiming at the stars for asymptomatic carotid artery atherosclerosis? Paraskevas KI, Wierzbicki AS, Mikhailidis DP. Int J Clin Pract. 2007 Aug;61(8):1242-6. No abstract available. PMID: 17627703 [PubMed - indexed for MEDLINE] Related citations 108. Targets--who needs them? Success with statin therapies. Wierzbicki AS. Int J Clin Pract. 2007 Aug;61(8):1239-42. No abstract available. PMID: 17627702 [PubMed - indexed for MEDLINE] Related citations 109. PCI and stable coronary heart disease--COURAGE to change our minds? Kakafika AI, Mikhailidis DP, Wierzbicki AS, Karagiannis A, Athyros VG. Curr Vasc Pharmacol. 2007 Jul;5(3):173-4. No abstract available. PMID: 17627560 [PubMed - indexed for MEDLINE] Related citations 110. Raising HDL-C: back to the future? Wierzbicki AS. Int J Clin Pract. 2007 Jul;61(7):1069-71. No abstract available. PMID: 17577290 [PubMed - indexed for MEDLINE] Related citations 111. Newer, lower, better? Lipid drugs and cardiovascular disease--the continuing story. Wierzbicki AS. Int J Clin Pract. 2007 Jul;61(7):1064-7. No abstract available. PMID: 17577288 [PubMed - indexed for MEDLINE] Related citations 112. Identifying patients with familial hypercholesterolaemia in primary care: an informatics-based approach in one primary care centre. Gray J, Jaiyeola A, Whiting M, Modell M, Wierzbicki AS. Heart. 2008 Jun;94(6):754-8. Epub 2007 Jun 17. PMID: 17575326 [PubMed - indexed for MEDLINE] Related citations 113. How aggressively should cholesterol targets be pursued? Wierzbicki AS. Br J Hosp Med (Lond). 2007 May;68(5):232-3. No abstract available. PMID: 17554938 [PubMed - indexed for MEDLINE] Related citations 114. Percentage non-caeruloplasmin bound copper. Twomey PJ, Wierzbicki AS, House IM, Viljoen A, Reynolds TM. Clin Biochem. 2007 Jun;40(9-10):749-50. Epub 2007 Apr 19. PMID: 17498678 [PubMed - indexed for MEDLINE] Related citations 115. Copper:caeruloplasmin ratio. Twomey PJ, Viljoen A, House IM, Reynolds TM, Wierzbicki AS.

14 of 37 J Clin Pathol. 2007 Apr;60(4):441-2. PMID: 17405985 [PubMed - indexed for MEDLINE] Free PMC Article Related citations 116. Proprotein convertase subtilisin/kexin type 9, its variants and regulation of low-density lipoprotein cholesterol. Wierzbicki AS. Curr Opin Lipidol. 2007 Apr;18(2):227-9. No abstract available. PMID: 17353672 [PubMed - indexed for MEDLINE] Related citations 117. Asymmetric dimethylarginine and reduced nitric oxide bioavailability in young Black African men. Melikian N, Wheatcroft SB, Ogah OS, Murphy C, Chowienczyk PJ, Wierzbicki AS, Sanders TA, Jiang B, Duncan ER, Shah AM, Kearney MT. Hypertension. 2007 Apr;49(4):873-7. Epub 2007 Jan 29. PMID: 17261643 [PubMed - indexed for MEDLINE] Free Article Related citations 118. Shape of the Nations survey and attitudes to cardiometabolic risk. Wierzbicki AS, Ganotakis ES, Mikhailidis DP. Curr Med Res Opin. 2007 Jan;23(1):25-8. No abstract available. PMID: 17261235 [PubMed - indexed for MEDLINE] Related citations 119. Differential effect of pioglitazone (PGZ) and rosiglitazone (RGZ) on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus: a prospective, randomized crossover study. Chappuis B, Braun M, Stettler C, Allemann S, Diem P, Lumb PJ, Wierzbicki AS, James R, Christ ER. Diabetes Metab Res Rev. 2007 Jul;23(5):392-9. PMID: 17211855 [PubMed - indexed for MEDLINE] Related citations 120. Lipid-altering therapies and the progression of atherosclerotic disease. Wierzbicki AS. Cardiovasc Intervent Radiol. 2007 Mar-Apr;30(2):155-60. Review. PMID: 17206389 [PubMed - indexed for MEDLINE] Related citations 121. Limitations of non-ceruloplasmin-bound copper in routine clinical practice. Twomey PJ, Viljoen A, House IM, Reynolds TM, Wierzbicki AS. Gut. 2007 Jan;56(1):154. No abstract available. PMID: 17172594 [PubMed - indexed for MEDLINE] Free PMC Article Related citations 122. Fibrates after the FIELD study: Some answers, more questions. Wierzbicki AS. Diab Vasc Dis Res. 2006 Dec;3(3):166-71. Review. PMID: 17160911 [PubMed - indexed for MEDLINE] Free Article Related citations 123. Rimonabant: endocannabinoid inhibition for the metabolic syndrome. Wierzbicki AS. Int J Clin Pract. 2006 Dec;60(12):1697-706. Review. Erratum in: Int J Clin Pract. 2007 Mar;61(3):534. PMID: 17109677 [PubMed - indexed for MEDLINE] Related citations

15 of 37 124. Low HDL-cholesterol: Common and under-treated, but which drug to use? Wierzbicki AS. Int J Clin Pract. 2006 Oct;60(10):1149-53. No abstract available. PMID: 16981959 [PubMed - indexed for MEDLINE] Related citations 125. Cardiovascular risk factors determine erectile and arterial function response to sildenafil. Solomon H, Wierzbicki AS, Lumb PJ, Lambert-Hammill M, Jackson G. Am J Hypertens. 2006 Sep;19(9):915-9. PMID: 16942933 [PubMed - indexed for MEDLINE] Related citations 126. Lipid lowering, statins and cancer. Wierzbicki AS. Int J Clin Pract. 2006 Sep;60(9):1022-4. No abstract available. PMID: 16939539 [PubMed - indexed for MEDLINE] Related citations 127. Spinning stars: ASTEROID's impact on atherosclerosis. Schachter M, Wierzbicki AS. Lancet. 2006 May 20;367(9523):1655-6. No abstract available. PMID: 16714182 [PubMed - indexed for MEDLINE] Related citations 128. Statins and hypertension. Wierzbicki AS. J Hum Hypertens. 2006 Aug;20(8):554-6. Epub 2006 May 4. No abstract available. PMID: 16673013 [PubMed - indexed for MEDLINE] Related citations 129. Adjusting copper concentrations for caeruloplasmin levels in routine clinical practice. Twomey PJ, Viljoen A, House IM, Reynolds TM, Wierzbicki AS. J Clin Pathol. 2006 Aug;59(8):867-9. Epub 2006 Apr 27. PMID: 16644878 [PubMed - indexed for MEDLINE] Free PMC Article Related citations 130. FIELDS of dreams, fields of tears: a perspective on the fibrate trials. Wierzbicki AS. Int J Clin Pract. 2006 Apr;60(4):442-9. Review. PMID: 16620358 [PubMed - indexed for MEDLINE] Related citations 131. Low-density lipoprotein apolipoprotein B100 turnover in hypopituitary patients with GH deficiency: a stable isotope study. Christ ER, Cummings MH, Stolinski M, Jackson N, Lumb PJ, Wierzbicki AS, Sönksen PH, Russell- Jones DL, Umpleby AM. Eur J Endocrinol. 2006 Mar;154(3):459-66. PMID: 16498060 [PubMed - indexed for MEDLINE] Free Article Related citations 132. Erectile dysfunction and statin treatment in high cardiovascular risk patients. Solomon H, Samarasinghe YP, Feher MD, Man J, Rivas-Toro H, Lumb PJ, Wierzbicki AS, Jackson G. Int J Clin Pract. 2006 Feb;60(2):141-5. PMID: 16451283 [PubMed - indexed for MEDLINE] Related citations

16 of 37 133. Plasma lipid profiles of women with intrahepatic cholestasis of pregnancy. Dann AT, Kenyon AP, Wierzbicki AS, Seed PT, Shennan AH, Tribe RM. Obstet Gynecol. 2006 Jan;107(1):106-14. PMID: 16394047 [PubMed - indexed for MEDLINE] Related citations 134. Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolaemia: relationship with plasma lipid traits, heart disease risk and utility in relative tracing. Humphries SE, Cranston T, Allen M, Middleton-Price H, Fernandez MC, Senior V, Hawe E, Iversen A, Wray R, Crook MA, Wierzbicki AS. J Mol Med (Berl). 2006 Mar;84(3):203-14. Epub 2005 Dec 31. PMID: 16389549 [PubMed - indexed for MEDLINE] Related citations 135. Dyslipidaemia and cardiovascular risk in HIV infection. Kulasekaram R, Peters BS, Wierzbicki AS. Curr Med Res Opin. 2005 Nov;21(11):1717-25. Review. PMID: 16307691 [PubMed - indexed for MEDLINE] Related citations 136. Very low plasma copper levels do not automatically imply severe copper deficiency. Twomey PJ, Viljoen A, House IM, Reynolds TM, Wierzbicki AS. Ann Clin Biochem. 2005 Sep;42(Pt 5):405; author reply 405-6. No abstract available. PMID: 16168200 [PubMed - indexed for MEDLINE] Related citations 137. Images in clinical medicine. Lipemia retinalis. Kumar J, Wierzbicki AS. N Engl J Med. 2005 Aug 25;353(8):823. No abstract available. PMID: 16120862 [PubMed - indexed for MEDLINE] Free Article Related citations 138. Impaired renal function and atherosclerosis in a Pakistani cohort. Wierzbicki AS, Nishtar S, Lumb PJ, Lambert-Hammill M, Crook MA, Marber MS, Gill J. Curr Med Res Opin. 2005 Aug;21(8):1201-7. PMID: 16083529 [PubMed - indexed for MEDLINE] Related citations 139. Asymmetric dimethyl arginine levels correlate with cardiovascular risk factors in patients with erectile dysfunction. Wierzbicki AS, Solomon H, Lumb PJ, Lyttle K, Lambert-Hammill M, Jackson G. Atherosclerosis. 2006 Apr;185(2):421-5. Epub 2005 Jul 25. PMID: 16046217 [PubMed - indexed for MEDLINE] Related citations 140. Relationship between serum copper, ceruloplasmin, and non-ceruloplasmin-bound copper in routine clinical practice. Twomey PJ, Viljoen A, House IM, Reynolds TM, Wierzbicki AS. Clin Chem. 2005 Aug;51(8):1558-9. No abstract available. PMID: 16040861 [PubMed - indexed for MEDLINE] Free Article Related citations 141. Metabolic syndrome and risk of coronary heart disease in a Pakistani cohort. Wierzbicki AS, Nishtar S, Lumb PJ, Lambert-Hammill M, Turner CN, Crook MA, Marber MS, Gill J. Heart. 2005 Aug;91(8):1003-7.

17 of 37 PMID: 16020583 [PubMed - indexed for MEDLINE] Free PMC Article Related citations 142. The use of ezetimibe in achieving low density lipoprotein lowering goals in clinical practice: position statement of a United Kingdom consensus panel. Mikhailidis DP, Wierzbicki AS, Daskalopoulou SS, Al-Saady N, Griffiths H, Hamilton G, Monkman D, Patel V, Pittard J, Schachter M. Curr Med Res Opin. 2005 Jun;21(6):959-69. PMID: 15969896 [PubMed - indexed for MEDLINE] Related citations 143. Ezetimibe-induced hyperlipidaemia. Doherty E, Lumb PJ, Chik G, Wierzbicki AS. Int J Clin Pract Suppl. 2005 Apr;(147):3-5. PMID: 15875607 [PubMed - indexed for MEDLINE] Related citations 144. Hypertriglyceridaemia and malignancy. Wijeratne S, Wray R, Collinson PO, Wierzbicki AS. Int J Clin Pract. 2005 Feb;59(2):253-5. PMID: 15854204 [PubMed - indexed for MEDLINE] Related citations 145. Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4alpha mutations in a large European collection. Pearson ER, Pruhova S, Tack CJ, Johansen A, Castleden HA, Lumb PJ, Wierzbicki AS, Clark PM, Lebl J, Pedersen O, Ellard S, Hansen T, Hattersley AT. Diabetologia. 2005 May;48(5):878-85. Epub 2005 Apr 14. PMID: 15830177 [PubMed - indexed for MEDLINE] Related citations 146. Cardiovascular risk assessment. Wierzbicki AS, Twomey PJ, Reynolds TM. Lancet. 2005 Apr 9-15;365(9467):1305-6. No abstract available. PMID: 15823374 [PubMed - indexed for MEDLINE] Related citations 147. Efficacy of ezetimibe in patients with statin-resistant and statin-intolerant familial hyperlipidaemias. Wierzbicki AS, Doherty E, Lumb PJ, Chik G, Crook MA. Curr Med Res Opin. 2005 Mar;21(3):333-8. PMID: 15811200 [PubMed - indexed for MEDLINE] Related citations 148. Have we forgotten the pivotal role of high-density lipoprotein cholesterol in atherosclerosis prevention? Wierzbicki AS. Curr Med Res Opin. 2005 Feb;21(2):299-306. Review. PMID: 15802001 [PubMed - indexed for MEDLINE] Related citations 149. A review of the lipid-related effects of fluvastatin. Liberopoulos EN, Daskalopoulou SS, Mikhailidis DP, Wierzbicki AS, Elisaf MS. Curr Med Res Opin. 2005 Feb;21(2):231-44. Review. PMID: 15801994 [PubMed - indexed for MEDLINE]

18 of 37 Related citations 150. Letter regarding article by Gazzaruso et al, "Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated, type 2 diabetic patients". Jackson G, Solomon H, Wierzbicki AS. Circulation. 2005 Jan 18;111(2):e18-9; author reply e18-9. No abstract available. PMID: 15657383 [PubMed - indexed for MEDLINE] Free Article Related citations 151. Lipid-altering agents: the future. Wierzbicki AS. Int J Clin Pract. 2004 Nov;58(11):1063-72. Review. PMID: 15605675 [PubMed - indexed for MEDLINE] Related citations 152. Clinical significance of oxidation from phytol to phytanic acid in man. Wierzbicki AS. Mol Genet Metab. 2004 Dec;83(4):347. No abstract available. PMID: 15589124 [PubMed - indexed for MEDLINE] Related citations 153. Raising high-density lipoprotein. Wierzbicki AS. Int J Clin Pract. 2004 Sep;58(9):817-9. No abstract available. PMID: 15529513 [PubMed - indexed for MEDLINE] Related citations 154. Genetics and molecular biology: genetic epidemiology. Wierzbicki AS. Curr Opin Lipidol. 2004 Dec;15(6):699-701. No abstract available. PMID: 15529030 [PubMed - indexed for MEDLINE] Related citations 155. Lipid-lowering therapies in development. Wierzbicki AS. Expert Opin Investig Drugs. 2004 Nov;13(11):1405-18. Review. PMID: 15500389 [PubMed - indexed for MEDLINE] Related citations 156. Chemical pathology and the new contract for GPs. Twomey PJ, Wierzbicki AS, Reynolds TM. J Clin Pathol. 2004 Oct;57(10):1022-4. No abstract available. PMID: 15452152 [PubMed - indexed for MEDLINE] Free PMC Article Related citations 157. Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes. Twomey PJ, Viljoen A, Reynolds TM, Wierzbicki AS. Diabetes Care. 2004 Oct;27(10):2569-70. No abstract available. PMID: 15451948 [PubMed - indexed for MEDLINE] Related citations 158. Cardiovascular risk factors and endothelial dysfunction. Wierzbicki AS, Chowienczyk PJ, Cockcroft JR, Brett SE, Watts GF, Jenkins BS, Ritter JM. Clin Sci (Lond). 2004 Dec;107(6):609-15. PMID: 15450002 [PubMed - indexed for MEDLINE] Free Article Related citations

19 of 37 159. Smell testing: an additional tool for identification of adult Refsum's disease. Gibberd FB, Feher MD, Sidey MC, Wierzbicki AS. J Neurol Neurosurg Psychiatry. 2004 Sep;75(9):1334-6. PMID: 15314127 [PubMed - indexed for MEDLINE] Free PMC Article Related citations 160. Psychological impact of genetic testing for familial hypercholesterolemia within a previously aware population: a randomized controlled trial. Marteau T, Senior V, Humphries SE, Bobrow M, Cranston T, Crook MA, Day L, Fernandez M, Horne R, Iversen A, Jackson Z, Lynas J, Middleton-Price H, Savine R, Sikorski J, Watson M, Weinman J, Wierzbicki AS, Wray R; Genetic Risk Assessment for FH Trial Study Group. Am J Med Genet A. 2004 Jul 30;128A(3):285-93. PMID: 15216550 [PubMed - indexed for MEDLINE] Related citations 161. Effect of moxonidine on lipid subfractions in patients with hypertension. Lumb PJ, McMahon Z, Chik G, Wierzbicki AS. Int J Clin Pract. 2004 May;58(5):465-8. PMID: 15206502 [PubMed - indexed for MEDLINE] Related citations 162. Concordance evaluation of coronary risk scores: implications for cardiovascular risk screening. Reynolds TM, Twomey PJ, Wierzbicki AS. Curr Med Res Opin. 2004 Jun;20(6):811-8. PMID: 15200737 [PubMed - indexed for MEDLINE] Related citations 163. Screening for cardiovascular disease. Wierzbicki AS, Twomey PJ, Reynolds TM. Eur Heart J. 2004 Jun;25(11):996; author reply 996-7. No abstract available. PMID: 15172476 [PubMed - indexed for MEDLINE] Free Article Related citations 164. Use of coronary calcification scores to predict coronary heart disease. Wierzbicki AS, Twomey PJ, Reynolds TM. JAMA. 2004 Apr 21;291(15):1831; author reply 1832-3. No abstract available. PMID: 15100193 [PubMed - indexed for MEDLINE] Related citations 165. Effects of growth hormone (GH) replacement therapy on low-density lipoprotein apolipoprotein B100 kinetics in adult patients with GH deficiency: a stable isotope study. Christ ER, Cummings MH, Jackson N, Stolinski M, Lumb PJ, Wierzbicki AS, Sönksen PH, Russell- Jones DL, Umpleby AM. J Clin Endocrinol Metab. 2004 Apr;89(4):1801-7. PMID: 15070948 [PubMed - indexed for MEDLINE] Related citations 166. Cost utility of prenatal diagnosis. Wierzbicki AS, Reynolds TM. Lancet. 2004 Apr 3;363(9415):1165. No abstract available. PMID: 15064049 [PubMed - indexed for MEDLINE] Related citations 167. Does activity in research correlate with visibility? Reynolds TM, Wierzbicki AS.

20 of 37 J Clin Pathol. 2004 Apr;57(4):426-7. PMID: 15047750 [PubMed - indexed for MEDLINE] Free PMC Article Related citations 168. Cardiovascular disease in renal allograft recipients is associated with elevated sialic acid or markers of inflammation. Bakri RS, Afzali B, Covic A, Sriskantharan R, Bharma-Ariza P, Park WH, Sriharan M, Dalton N, Wierzbicki AS, Crook MA, Goldsmith DJ. Clin Transplant. 2004 Apr;18(2):201-4. PMID: 15016136 [PubMed - indexed for MEDLINE] Related citations 169. The casino of life. Twomey PJ, Reynolds TM, Wierzbicki AS. J Clin Pathol. 2004 Mar;57(3):243-4. No abstract available. PMID: 14990592 [PubMed - indexed for MEDLINE] Free PMC Article Related citations 170. Waist-hip ratio and low HDL predict the risk of coronary artery disease in Pakistanis. Nishtar S, Wierzbicki AS, Lumb PJ, Lambert-Hammill M, Turner CN, Crook MA, Mattu MA, Shahab S, Badar A, Ehsan A, Marber MS, Gill J. Curr Med Res Opin. 2004 Jan;20(1):55-62. PMID: 14741073 [PubMed - indexed for MEDLINE] Related citations 171. Drug treatment of combined hyperlipidemia. Wierzbicki AS, Mikhailidis DP, Wray R. Am J Cardiovasc Drugs. 2001;1(5):327-36. Review. PMID: 14728015 [PubMed - indexed for MEDLINE] Related citations 172. Polymorphisms in the P450 c17 (17-hydroxylase/17,20-Lyase) and P450 c19 (aromatase) genes: association with serum sex steroid concentrations and bone mineral density in postmenopausal women. Somner J, McLellan S, Cheung J, Mak YT, Frost ML, Knapp KM, Wierzbicki AS, Wheeler M, Fogelman I, Ralston SH, Hampson GN. J Clin Endocrinol Metab. 2004 Jan;89(1):344-51. PMID: 14715870 [PubMed - indexed for MEDLINE] Related citations 173. Role of phytanoyl-CoA 2-hydroxylase in phytanic acid metabolism. Lloyd MD, Mukherji M, Kershaw NJ, Chien W, Wierzbicki AS, Schofield CJ. Adv Exp Med Biol. 2003;544:303-4. No abstract available. PMID: 14713244 [PubMed - indexed for MEDLINE] Related citations 174. Identification of PEX7 as the second gene involved in Refsum disease. Van den Brink DM, Brites P, Haasjes J, Wierzbicki AS, Mitchell J, Lambert-Hamill M, de Belleroche J, Jansen GA, Waterham HR, Wanders RJ. Adv Exp Med Biol. 2003;544:69-70. No abstract available. PMID: 14713215 [PubMed - indexed for MEDLINE] Related citations 175. Hypertriglyceridaemia and NK cell lymphoma. Suryanarayanan S, Wierzbicki AS, Carr R, Ritter JM.

21 of 37 Int J Clin Pract. 2003 Dec;57(10):921-2. PMID: 14712900 [PubMed - indexed for MEDLINE] Related citations 176. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients. Afzali B, Bakri RS, Bharma-Ariza P, Lumb PJ, Dalton N, Turner NC, Wierzbicki AS, Crook MA, Goldsmith DJ. J Nephrol. 2003 Jul-Aug;16(4):540-5. PMID: 14696756 [PubMed - indexed for MEDLINE] Related citations 177. Issues to consider when attempting to achieve the American Diabetes Association clinical quality requirement for haemoglobin A1c. Twomey PJ, Wierzbicki AS, Reynolds TM. Curr Med Res Opin. 2003;19(8):719-23. Review. PMID: 14687443 [PubMed - indexed for MEDLINE] Related citations 178. New lipid-lowering agents. Wierzbicki AS. Expert Opin Emerg Drugs. 2003 Nov;8(2):365-76. Review. PMID: 14661995 [PubMed - indexed for MEDLINE] Related citations 179. Ezetimibe: a new addition to lipid-lowering therapy. Wierzbicki AS. Int J Clin Pract. 2003 Oct;57(8):653-5. No abstract available. PMID: 14627172 [PubMed - indexed for MEDLINE] Related citations 180. Simple sequence-specific-primer-PCR method to identify the three main apolipoprotein E haplotypes. Pantelidis P, Lambert-Hammill M, Wierzbicki AS. Clin Chem. 2003 Nov;49(11):1945-8. No abstract available. PMID: 14578332 [PubMed - indexed for MEDLINE] Free Article Related citations 181. Cerivastatin monotherapy-induced muscle weakness, rhabdomyolysis and acute renal failure. Bakri R, Wang J, Wierzbicki AS, Goldsmith D. Int J Cardiol. 2003 Sep;91(1):107-9. PMID: 12957739 [PubMed - indexed for MEDLINE] Related citations 182. Treatment-to-target for lipids in primary care. Wierzbicki AS. Int J Clin Pract. 2003 Jul-Aug;57(6):459-60. No abstract available. PMID: 12918882 [PubMed - indexed for MEDLINE] Related citations 183. The chemical biology of branched-chain lipid metabolism. Mukherji M, Schofield CJ, Wierzbicki AS, Jansen GA, Wanders RJ, Lloyd MD. Prog Lipid Res. 2003 Sep;42(5):359-76. Review. PMID: 12814641 [PubMed - indexed for MEDLINE] Related citations

22 of 37 184. Statin-fibrate combination: therapy for hyperlipidemia: a review. Wierzbicki AS, Mikhailidis DP, Wray R, Schacter M, Cramb R, Simpson WG, Byrne CB. Curr Med Res Opin. 2003;19(3):155-68. Review. PMID: 12814127 [PubMed - indexed for MEDLINE] Related citations 185. The lipid and non-lipid effects of statins. Wierzbicki AS, Poston R, Ferro A. Pharmacol Ther. 2003 Jul;99(1):95-112. Review. PMID: 12804701 [PubMed - indexed for MEDLINE] Related citations 186. Aggressive lipid-lowering therapy in high-risk groups: warranted or excessive? Wierzbicki AS. Int J Clin Pract. 2003 May;57(4):256-7. No abstract available. PMID: 12800452 [PubMed - indexed for MEDLINE] Related citations 187. Combination fibrate-statin therapy for the treatment of severe hypertriglyceridaemia in renal disease. Badawy O, Wierzbicki AS, Hilton R. Int J Clin Pract. 2003 Apr;57(3):249-51. PMID: 12723736 [PubMed - indexed for MEDLINE] Related citations 188. Metabolism of phytanic acid and 3-methyl-adipic acid excretion in patients with adult Refsum disease. Wierzbicki AS, Mayne PD, Lloyd MD, Burston D, Mei G, Sidey MC, Feher MD, Gibberd FB. J Lipid Res. 2003 Aug;44(8):1481-8. Epub 2003 Apr 16. PMID: 12700346 [PubMed - indexed for MEDLINE] Free Article Related citations 189. More on PROSPER. Wierzbicki AS, Mikhailidis DP, Reynolds TM. Lancet. 2003 Mar 29;361(9363):1135-6; author reply 1136. No abstract available. PMID: 12672344 [PubMed - indexed for MEDLINE] Related citations 190. Erectile dysfunction: cardiovascular risk and the role of the cardiologist. Solomon H, Man J, Wierzbicki AS, O'Brien T, Jackson G. Int J Clin Pract. 2003 Mar;57(2):96-9. PMID: 12661790 [PubMed - indexed for MEDLINE] Related citations 191. Accuracy of cardiovascular risk estimation. Reynolds TM, Twomey P, Wierzbicki AS. Clin Chem. 2003 Apr;49(4):706-7. No abstract available. PMID: 12651839 [PubMed - indexed for MEDLINE] Free Article Related citations 192. Statin therapy in people with diabetes and high-risk patients. Wierzbicki AS. Hosp Med. 2003 Jan;64(1):16-9. Review. PMID: 12572329 [PubMed - indexed for MEDLINE] Related citations

23 of 37 193. Does evidence-based medicine provide evidence? The evidence on breast cancer and the safety of oral contraceptives suggests that unorthodox interpretations may be just as valid. Reynolds TM, Wierzbicki AS. Breast J. 2003 Jan-Feb;9(1):66-7. No abstract available. PMID: 12558680 [PubMed - indexed for MEDLINE] Related citations 194. Identification of PEX7 as the second gene involved in Refsum disease. van den Brink DM, Brites P, Haasjes J, Wierzbicki AS, Mitchell J, Lambert-Hamill M, de Belleroche J, Jansen GA, Waterham HR, Wanders RJ. Am J Hum Genet. 2003 Feb;72(2):471-7. Epub 2003 Jan 9. PMID: 12522768 [PubMed - indexed for MEDLINE] Free PMC Article Related citations 195. Relation of erectile dysfunction to angiographic coronary artery disease. Solomon H, Man JW, Wierzbicki AS, Jackson G. Am J Cardiol. 2003 Jan 15;91(2):230-1. No abstract available. PMID: 12521639 [PubMed - indexed for MEDLINE] Related citations 196. Lipid lowering: another method of reducing blood pressure? Wierzbicki AS. J Hum Hypertens. 2002 Nov;16(11):753-60. Review. PMID: 12444536 [PubMed - indexed for MEDLINE] Free Article Related citations 197. Accuracy of cardiovascular risk estimation for primary prevention in patients without diabetes. Reynolds TM, Twomey P, Wierzbicki AS. J Cardiovasc Risk. 2002 Aug;9(4):183-90. PMID: 12394326 [PubMed - indexed for MEDLINE] Related citations 198. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. Mikhailidis DP, Wierzbicki AS. Curr Med Res Opin. 2002;18(4):215-9. No abstract available. PMID: 12201622 [PubMed - indexed for MEDLINE] Related citations 199. The apolipoprotein E2 allele modulates activity and maximal velocity of the sodium-lithium countertransporter. Wierzbicki AS, Hardman TC, Cheung J, Lambert-Hammill M, Patel S, Morrish Z, Lumb PJ, Lant AF. Am J Hypertens. 2002 Jul;15(7 Pt 1):633-7. PMID: 12118912 [PubMed - indexed for MEDLINE] Related citations 200. Dose-response effects of atorvastatin and simvastatin on high-density lipoprotein cholesterol in hypercholesterolaemic patients: a review of five comparative studies. Wierzbicki AS, Mikhailidis DP. Int J Cardiol. 2002 Jul;84(1):53-7. PMID: 12104065 [PubMed - indexed for MEDLINE] 201. Total research productivity in a pathology discipline. Wierzbicki AS, Reynolds TM. J Clin Pathol. 2002 Jul;55(7):495-8. PMID: 12101192 [PubMed - indexed for MEDLINE] Free PMC Article

24 of 37 Related citations 202. Utilization of sterol carrier protein-2 by phytanoyl-CoA 2-hydroxylase in the peroxisomal alpha oxidation of phytanic acid. Mukherji M, Kershaw NJ, Schofield CJ, Wierzbicki AS, Lloyd MD. Chem Biol. 2002 May;9(5):597-605. PMID: 12031666 [PubMed - indexed for MEDLINE] Related citations 203. Beyond LDL-C--the importance of raising HDL-C. Wierzbicki AS, Mikhailidis DP. Curr Med Res Opin. 2002;18(1):36-44. Review. PMID: 11999145 [PubMed - indexed for MEDLINE] Related citations 204. Stroke in systemic lupus erythematosus. Wierzbicki AS. Expert Rev Neurother. 2002 May;2(3):385-90. doi: 10.1586/14737175.2.3.385. PMID: 19810870 [PubMed] Related citations 205. Refsum's disease: a peroxisomal disorder affecting phytanic acid alpha-oxidation. Wierzbicki AS, Lloyd MD, Schofield CJ, Feher MD, Gibberd FB. J Neurochem. 2002 Mar;80(5):727-35. Review. PMID: 11948235 [PubMed - indexed for MEDLINE] Related citations 206. Effect of IGF-I therapy on VLDL apolipoprotein B100 metabolism in type 1 diabetes mellitus. Christ ER, Carroll PV, Albany E, Umpleby AM, Lumb PJ, Wierzbicki AS, Sönksen PH, Russell-Jones DL. Am J Physiol Endocrinol Metab. 2002 May;282(5):E1154-62. PMID: 11934682 [PubMed - indexed for MEDLINE] Free Article Related citations 207. Normal VLDL metabolism despite altered lipoprotein composition in type 1 diabetes mellitus. Christ ER, Carroll PV, Albany E, Umpleby AM, Lumb PJ, Wierzbicki AS, Simpson HL, Sönksen PH, Russell-Ones DL. Clin Endocrinol (Oxf). 2001 Dec;55(6):777-87. PMID: 11895220 [PubMed - indexed for MEDLINE] Related citations 208. The uptake of lipoprotein-borne phylloquinone (vitamin K1) by osteoblasts and osteoblast-like cells: role of heparan sulfate proteoglycans and apolipoprotein E. Newman P, Bonello F, Wierzbicki AS, Lumb P, Savidge GF, Shearer MJ. J Bone Miner Res. 2002 Mar;17(3):426-33. PMID: 11874234 [PubMed - indexed for MEDLINE] Related citations 209. Usefulness of Orlistat in the treatment of severe hypertriglyceridemia. Wierzbicki AS, Reynolds TM, Crook MA. Am J Cardiol. 2002 Jan 15;89(2):229-31. No abstract available. PMID: 11792350 [PubMed - indexed for MEDLINE] Related citations 210. Comparison of therapy with simvastatin 80 mg and 120 mg in patients with familial hypercholesterolaemia.

25 of 37 Wierzbicki AS, Lumb PJ, Chik G. Int J Clin Pract. 2001 Dec;55(10):673-5. PMID: 11777291 [PubMed - indexed for MEDLINE] Related citations 211. Very low-density lipoprotein apolipoprotein B-100 turnover in glycogen storage disease type Ia (von Gierke disease). Wierzbicki AS, Watt GF, Lynas J, Winder AF, Wray R. J Inherit Metab Dis. 2001 Oct;24(5):527-34. PMID: 11757580 [PubMed - indexed for MEDLINE] Related citations 212. Is universal antenatal HIV screening ethical outside London? Reynolds TM, Wierzbicki AS. Bull Med Ethics. 1999 Nov;No. 152:2. No abstract available. PMID: 11658083 [PubMed - indexed for MEDLINE] Related citations 213. Structure-function analysis of phytanoyl-CoA 2-hydroxylase mutations causing Refsum's disease. Mukherji M, Chien W, Kershaw NJ, Clifton IJ, Schofield CJ, Wierzbicki AS, Lloyd MD. Hum Mol Genet. 2001 Sep 1;10(18):1971-82. PMID: 11555634 [PubMed - indexed for MEDLINE] Free Article Related citations 214. Studies on phytanoyl-CoA 2-hydroxylase and synthesis of phytanoyl-coenzyme A. Kershaw NJ, Mukherji M, MacKinnon CH, Claridge TD, Odell B, Wierzbicki AS, Lloyd MD, Schofield CJ. Bioorg Med Chem Lett. 2001 Sep 17;11(18):2545-8. PMID: 11549466 [PubMed - indexed for MEDLINE] Related citations 215. Vascular and blood pressure effects of folic acid in older patients with cardiovascular disease. Mangoni AA, Ouldred E, Swif CG, Jackson SH, Draper RP, Sherwood RA, Lambert-Hammill M, Wierzbicki AS. J Am Geriatr Soc. 2001 Jul;49(7):1003-4. No abstract available. PMID: 11527499 [PubMed - indexed for MEDLINE] Related citations 216. Measurement of atherosclerosis progression. Wierzbicki AS, Crook MA, Reynolds TM, Mikhalidis DP. Lancet. 2001 Jul 28;358(9278):329-30. No abstract available. PMID: 11501530 [PubMed - indexed for MEDLINE] Related citations 217. Atorvastatin for acute coronary syndromes. Wierzbicki AS, Mikhaildis DP, Reynolds TR. JAMA. 2001 Aug 1;286(5):532-3; author reply 533-5. No abstract available. PMID: 11476649 [PubMed - indexed for MEDLINE] Related citations 218. Time to look beyond just lowering the serum concentration of low density lipoprotein--high density lipoprotein levels are also important. Nair DR, Wierzbicki AS, Mikhailidis DP. J R Soc Promot Health. 2001 Jun;121(2):98-101. Review. PMID: 11467215 [PubMed - indexed for MEDLINE]

26 of 37 Related citations 219. Synthetic statins: more data on newer lipid-lowering agents. Wierzbicki AS. Curr Med Res Opin. 2001;17(1):74-7. Review. PMID: 11464449 [PubMed - indexed for MEDLINE] Related citations 220. Erythrocyte sodium-lithium countertransport in African American women. Hardman TC, Wierzbicki AS. J Hum Hypertens. 2001 Jul;15(7):505-6. No abstract available. PMID: 11464263 [PubMed - indexed for MEDLINE] Free Article Related citations 221. Is a mechanical or a metabolic approach superior in the treatment of coronary disease? Results of the atorvastatin versus revascularization (AVERT) trial. Mikhaildis DP, Wierzbicki AS, Reynolds TM. Eur Heart J. 2001 Jun;22(11):972-3. No abstract available. PMID: 11428822 [PubMed - indexed for MEDLINE] Free Article Related citations 222. Statins and fractures. Wierzbicki AS, Reynolds TM. Lancet. 2001 Jun 9;357(9271):1887-9. No abstract available. PMID: 11417585 [PubMed - indexed for MEDLINE] Related citations 223. Atorvastatin. Wierzbicki AS. Expert Opin Pharmacother. 2001 May;2(5):819-30. Review. PMID: 11336625 [PubMed - indexed for MEDLINE] Related citations 224. Is a statin a statin? Wierzbicki AS. Int J Clin Pract. 2001 Mar;55(2):79-80. No abstract available. PMID: 11321864 [PubMed - indexed for MEDLINE] Related citations 225. Lipid-lowering drugs in lupus: an unexplored therapeutic intervention. Wierzbicki AS. Lupus. 2001;10(3):233-6. Review. PMID: 11315359 [PubMed - indexed for MEDLINE] Related citations 226. Relation between sodium-lithium countertransport and hypertriglyceridemia in type V hyperlipidemia. Wierzbicki AS, Hardman TC, Cheung J, Patel M, Smallberger S, Lumb PJ, Lant AF. Am J Hypertens. 2001 Jan;14(1):32-7. PMID: 11206676 [PubMed - indexed for MEDLINE] Related citations 227. National service framework's financial implications are huge. Wierzbicki AS, Reynolds TM. BMJ. 2000 Sep 16;321(7262):705. No abstract available. PMID: 11202938 [PubMed - indexed for MEDLINE] Free PMC Article

27 of 37 Related citations 228. Attaining United States and European guideline LDL-C levels with simvastatin in patients with coronary heart disease (the GOALLS study). Mikhailidis DP, Wierzbicki AS. Curr Med Res Opin. 2000;16(3):205-7. No abstract available. PMID: 11191011 [PubMed - indexed for MEDLINE] Related citations 229. Survival and reduction in mortality from breast cancer. Improvements in survival may be an illusion. Reynolds TM, Wierzbicki AS. BMJ. 2000 Dec 9;321(7274):1471; author reply 1471-2. No abstract available. PMID: 11187949 [PubMed - indexed for MEDLINE] Related citations 230. Fibrinogen response with simvastatin versus atorvastatin in familial hypercholesterolemia. Wierzbicki AS, Lumb PJ, Chik G, Crook MA. Am J Cardiol. 2001 Feb 1;87(3):338-40, A9. PMID: 11165973 [PubMed - indexed for MEDLINE] Related citations 231. Differing relationships of methylene tetrahydrofolate reductase genotypes with cardiovascular risk in familial and polygenic hypercholesterolaemia. Wierzbicki AS, Lambert-Hammill M, Junadi E, Lumb PJ, Crook MA. J Cardiovasc Risk. 2000 Dec;7(6):431-4. PMID: 11155296 [PubMed - indexed for MEDLINE] Related citations 232. Renin-angiotensin system polymorphisms and coronary events in familial hypercholesterolemia. Wierzbicki AS, Lambert-Hammill M, Lumb PJ, Crook MA. Hypertension. 2000 Nov;36(5):808-12. PMID: 11082147 [PubMed - indexed for MEDLINE] Free Article Related citations 233. The implications of the National Service Framework for coronary heart disease. Wierzbicki AS. J R Soc Promot Health. 2000 Sep;120(3):143-5. No abstract available. PMID: 11077793 [PubMed - indexed for MEDLINE] Related citations 234. Effects of statins. Reynolds TM, Wierzbicki AS. Lancet. 2000 Sep 30;356(9236):1195. No abstract available. PMID: 11030324 [PubMed - indexed for MEDLINE] Related citations 235. High-density lipoprotein cholesterol and triglyceride response with simvastatin versus atorvastatin in familial hypercholesterolemia. Wierzbicki AS, Lumb PJ, Chik G, Crook MA. Am J Cardiol. 2000 Sep 1;86(5):547-9, A9. PMID: 11009276 [PubMed - indexed for MEDLINE] Related citations 236. Effects of lipids in patients with familial hypercholesterolaemia on the kinetics of the sodium- lithium countertransporter.

28 of 37 Wierzbicki AS, Hardman TC, Cheung J, Lambert-Hammill M, Patel S, Morrish Z, Lumb PJ, Lant AF. J Hum Hypertens. 2000 Sep;14(9):561-5. PMID: 10980587 [PubMed - indexed for MEDLINE] Related citations 237. Identification of genetic heterogeneity in Refsum's disease. Wierzbicki AS, Mitchell J, Lambert-Hammill M, Hancock M, Greenwood J, Sidey MC, de Belleroche J, Gibberd FB. Eur J Hum Genet. 2000 Aug;8(8):649-51. PMID: 10951529 [PubMed - indexed for MEDLINE] Free Article Related citations 238. Coronary heart disease in Indian Asians. Wierzbicki AS, Swaminathan R. Lancet. 2000 May 13;355(9216):1727-8. No abstract available. PMID: 10905273 [PubMed - indexed for MEDLINE] Related citations 239. HDL-cholesterol and the treatment of coronary heart disease: contrasting effects of atorvastatin and simvastatin. Mikhailidis DP, Wierzbicki AS. Curr Med Res Opin. 2000;16(2):139-46. Review. PMID: 10893658 [PubMed - indexed for MEDLINE] Related citations 240. Cost effectiveness of statins. Wierzbicki AS, Reynolds TM. Heart. 2000 Jun;83(6):713-4. No abstract available. PMID: 10885942 [PubMed - indexed for MEDLINE] Free PMC Article Related citations 241. Does diet have a role in the treatment of hyperlipidaemia? Wierzbicki AS. Int J Clin Pract. 2000 Mar;54(2):72-3. No abstract available. PMID: 10824358 [PubMed - indexed for MEDLINE] Related citations 242. Lipids, cardiovascular disease and atherosclerosis in systemic lupus erythematosus. Wierzbicki AS. Lupus. 2000;9(3):194-201. Review. PMID: 10805487 [PubMed - indexed for MEDLINE] Related citations 243. Serum homocysteine, folate and thermolabile variant of MTHFR in healthy Sri Lankans living in London. Alagratnam D, Wierzbicki AS, Swaminathan R, Turner C, Wickramasinghe SN. Atherosclerosis. 2000 Mar;149(1):221-2. No abstract available. PMID: 10799015 [PubMed - indexed for MEDLINE] Related citations 244. A comparison of algorithms for initiation of lipid lowering therapy in primary prevention of coronary heart disease. Wierzbicki AS, Reynolds TM, Gill K, Alg S, Crook MA. J Cardiovasc Risk. 2000 Feb;7(1):63-71. PMID: 10785876 [PubMed - indexed for MEDLINE]

29 of 37 Related citations 245. Classification of acute MI. Reynolds TM, Wierzbicki AS. Eur Heart J. 2000 May;21(10):857-8. No abstract available. PMID: 10781359 [PubMed - indexed for MEDLINE] Free Article Related citations 246. A randomised placebo controlled trial of the effects of tibolone on blood pressure and lipids in hypertensive women. Lloyd G, McGing E, Cooper A, Patel N, Lumb PJ, Wierzbicki AS, Jackson G. J Hum Hypertens. 2000 Feb;14(2):99-104. PMID: 10723115 [PubMed - indexed for MEDLINE] Related citations 247. Comparison of therapy with simvastatin 80 mg and atorvastatin 80 mg in patients with familial hypercholesterolaemia. Wierzbicki AS, Lumb PJ, Chik G, Crook MA. Int J Clin Pract. 1999 Dec;53(8):609-11. PMID: 10692755 [PubMed - indexed for MEDLINE] Related citations 248. Are drugs interchangeable? Wierzbicki AS, Reynolds TM, Crook MA, Jackson G. Lancet. 2000 Jan 22;355(9200):317; author reply 317-8. No abstract available. PMID: 10675097 [PubMed - indexed for MEDLINE] Related citations 249. Natural statins and stroke. Wierzbicki AS, Crook MA, Mikhailidis DP, Winder AF. Circulation. 2000 Jan 25;101(3):E45. No abstract available. PMID: 10645940 [PubMed - indexed for MEDLINE] Free Article Related citations 250. More on the effect of atorvastatin on plasma fibrinogen levels in primary hypercholesterolaemia. Wierzbicki AS, Crook MA, Nair DR, Mikhailidis DP, Winder AF. Atherosclerosis. 2000 Jan;148(1):204. No abstract available. PMID: 10644290 [PubMed - indexed for MEDLINE] Related citations 251. Atorvastatin compared with simvastatin-based therapies in the management of severe familial hyperlipidaemias. Wierzbicki AS, Lumb PJ, Semra Y, Chik G, Christ ER, Crook MA. QJM. 1999 Jul;92(7):387-94. PMID: 10627888 [PubMed - indexed for MEDLINE] Free Article Related citations 252. Urinary retinol-binding protein (RBP) excretion and erythrocyte sodium-lithium countertransport (SLC) activity in a cohort of healthy normotensive subjects. Hardman TC, Dubrey SW, Soni S, Clifford R, Chalkley S, Wierzbicki AS. J Hum Hypertens. 1999 Dec;13(12):871-3. No abstract available. PMID: 10618681 [PubMed - indexed for MEDLINE] Related citations 253. Erythrocyte Na+/Li+ countertransport and Na+/K+ -2Cl- co-transport in essential hypertension. Hardman T, Clifford RH, Wierzbicki AS.

30 of 37 Clin Sci (Lond). 1999 Sep;97(3):339-41. No abstract available. PMID: 10576963 [PubMed - indexed for MEDLINE] Free Article Related citations 254. Cholestatic liver dysfunction. Wierzbicki AS, Crook MA. Lancet. 1999 Sep 11;354(9182):954. No abstract available. PMID: 10489985 [PubMed - indexed for MEDLINE] Related citations 255. Thrombotic vascular events after change of statin. Wierzbicki AS, Crook MA, Reynolds TM, Jackson G. Lancet. 1999 Mar 6;353(9155):845. No abstract available. PMID: 10459992 [PubMed - indexed for MEDLINE] Related citations 256. Dynamics of lipoprotein metabolism in adult growth hormone deficiency. Christ ER, Wierzbicki AS, Cummings MH, Umpleby AM, Russell-Jones DL. J Endocrinol Invest. 1999;22(5 Suppl):16-21. Review. PMID: 10442565 [PubMed - indexed for MEDLINE] Related citations 257. The role of lipid lowering in transplantation. Wierzbicki AS. Int J Clin Pract. 1999 Jan-Feb;53(1):54-9. Review. PMID: 10344068 [PubMed - indexed for MEDLINE] Related citations 258. Transport of phytanic acid on lipoproteins in Refsum disease. Wierzbicki AS, Sankaralingam A, Lumb PJ, Hardman TC, Sidey MC, Gibberd FB. J Inherit Metab Dis. 1999 Feb;22(1):29-36. PMID: 10070615 [PubMed - indexed for MEDLINE] Related citations 259. Cholesterol: how low is low enough? Doctors have been slow in getting evidence on lowering cholesterol into practice. Wierzbicki AS, Reynolds TM. BMJ. 1999 Feb 20;318(7182):539. No abstract available. PMID: 10094544 [PubMed - indexed for MEDLINE] Related citations 260. Effects of growth hormone (GH) replacement therapy on very low density lipoprotein apolipoprotein B100 kinetics in patients with adult GH deficiency: a stable isotope study. Christ ER, Cummings MH, Albany E, Umpleby AM, Lumb PJ, Wierzbicki AS, Naoumova RP, Boroujerdi MA, Sönksen PH, Russell-Jones DL. J Clin Endocrinol Metab. 1999 Jan;84(1):307-16. PMID: 9920100 [PubMed - indexed for MEDLINE] Related citations 261. Lipid lowering therapy in patients with HIV infection. Wierzbicki AS, Reynolds TM, Crook MA, Tatler J, Peters BS. Lancet. 1998 Nov 28;352(9142):1782. No abstract available. PMID: 9848376 [PubMed - indexed for MEDLINE] Related citations 262. Profound hyponatraemia following an idiosyncratic reaction to diuretics.

31 of 37 Wierzbicki AS, Ball SG, Singh NK. Int J Clin Pract. 1998 Jun;52(4):278-9. PMID: 9744159 [PubMed - indexed for MEDLINE] Related citations 263. High-dose atorvastatin therapy in severe heterozygous familial hypercholesterolaemia. Wierzbicki AS, Lumb PJ, Semra YK, Crook MA. QJM. 1998 Apr;91(4):291-4. PMID: 9666952 [PubMed - indexed for MEDLINE] Free Article Related citations 264. People at risk of coronary heart disease should not be denied treatment with effective drugs for purely financial reasons. Reynolds TM, Wierzbicki AS, Crook MA, Capps NE. BMJ. 1998 Jul 4;317(7150):80. No abstract available. PMID: 9651289 [PubMed - indexed for MEDLINE] Free PMC Article Related citations 265. Influence of plasma phytanic acid levels in Refsum's disease on the behaviour of the erythrocyte membrane sodium-lithium countertransporter. Wierzbicki AS, Hardman TC, Lumb P, Sankaralingam A, Morrish Z, Patel F, Sidey MC, Gibberd FB. Eur J Clin Invest. 1998 Apr;28(4):334-8. PMID: 9615914 [PubMed - indexed for MEDLINE] Related citations 266. Effect of atorvastatin on plasma fibrinogen. Wierzbicki AS, Lumb PJ, Semra YK, Crook MA. Lancet. 1998 Feb 21;351(9102):569-70. No abstract available. PMID: 9492781 [PubMed - indexed for MEDLINE] Related citations 267. Diagnosis and management of hyperlipidaemia. Wierzbicki AS. Int J Clin Pract. 1997 Sep;51(6):378-83. Review. PMID: 9489067 [PubMed - indexed for MEDLINE] Related citations 268. Laboratory investigations by DNA amplification: from research to practice. Wierzbicki AS. Ann Clin Biochem. 1998 Jan;35 ( Pt 1):5-11. Review. No abstract available. PMID: 9463735 [PubMed - indexed for MEDLINE] Related citations 269. Fenofibrate plus simvastatin therapy versus simvastatin plus cholestyramine therapy for familial hypercholesterolaemia. Wierzbicki AS, Lumb PJ, Cheung J, Crook MA. QJM. 1997 Oct;90(10):631-4. PMID: 9415344 [PubMed - indexed for MEDLINE] Free Article Related citations 270. Use of statins. Guidelines need to concentrate on reducing overall cardiovascular risk. Wierzbicki AS, Reynolds TM. BMJ. 1997 Dec 13;315(7122):1616-7. No abstract available. PMID: 9437289 [PubMed - indexed for MEDLINE] Free PMC Article Related citations

32 of 37 271. Hyperlipidaemia in association with benign paraproteinaemia. Johnston JD, Lumb PJ, Wierzbicki AS. Ann Clin Biochem. 1997 Nov;34 ( Pt 6):697-9. No abstract available. PMID: 9367013 [PubMed - indexed for MEDLINE] Related citations 272. Ambiguities in angiotensin-converting enzyme allele genotyping: a comparison of three methods. Wierzbicki AS, Nimmo L, Lambert M. J Hum Hypertens. 1997 Jul;11(7):467-8. No abstract available. PMID: 9283065 [PubMed - indexed for MEDLINE] Related citations 273. Preserved endothelial function in patients with severe hypertriglyceridemia and low functional lipoprotein lipase activity. Chowienczyk PJ, Watts GF, Wierzbicki AS, Cockcroft JR, Brett SE, Ritter JM. J Am Coll Cardiol. 1997 Apr;29(5):964-8. PMID: 9120182 [PubMed - indexed for MEDLINE] Related citations 274. Familial hyperchylomicronaemia. Wierzbicki AS, Reynolds TM. Lancet. 1996 Nov 30;348(9040):1524-5. No abstract available. PMID: 8942817 [PubMed - indexed for MEDLINE] Related citations 275. Cardiac troponin T in unstable angina. Troponin T could be used to identify patients needing early treatment. Wierzbicki AS, Reynolds TM. BMJ. 1996 Nov 23;313(7068):1330; author reply 1330-1. No abstract available. PMID: 8942703 [PubMed - indexed for MEDLINE] Free PMC Article Related citations 276. Cost effectiveness of lowering cholesterol. Full treatment of the costs and benefits is needed. Wierzbicki AS, Reynolds TM. BMJ. 1996 Nov 2;313(7065):1143; author reply 1144. No abstract available. PMID: 8916709 [PubMed - indexed for MEDLINE] Free PMC Article Related citations 277. Patients with recurrent renal stones have a physico-chemically altered urinary Tamm-Horsfall glycoprotein profile. Jefferson A, Reynolds TM, Elves A, Wierzbicki AS. Ann Clin Biochem. 1996 Nov;33 ( Pt 6):540-4. PMID: 8937586 [PubMed - indexed for MEDLINE] Related citations 278. Sheffield risk and treatment table for primary prevention of coronary heart disease. Wierzbicki AS, Reynolds TM. Lancet. 1996 Oct 12;348(9033):1039-40; author reply 1040-1. No abstract available. PMID: 8855895 [PubMed - indexed for MEDLINE] Related citations 279. Angiotensin-converting enzyme (ACE) gene polymorphism and the erythrocyte sodium-lithium countertransporter (SLC) phenotype in hypertension. Hardman TC, Wierzbicki AS, Croft P, Feher M, Cox A, Lant AF. J Hum Hypertens. 1996 Jun;10(6):429-30.

33 of 37 PMID: 8872813 [PubMed - indexed for MEDLINE] Related citations 280. Sheffield risk and treatment table for cholesterol lowering in prevention of coronary heart disease. Wierzbicki AS, Reynolds TM. Lancet. 1996 Feb 17;347(8999):466-7; author reply 468-9. No abstract available. PMID: 8618499 [PubMed - indexed for MEDLINE] Related citations 281. Measurement of sodium-lithium countertransport kinetics. Wierzbicki AS. Hypertension. 1996 Feb;27(2):315; author reply 316. No abstract available. PMID: 8567061 [PubMed - indexed for MEDLINE] Free Article Related citations 282. Ethnic origin and hypertension-associated alterations in sodium-lithium countertransport kinetics. Hardman TC, Croft P, Barlow R, Wierzbicki AS, Feher MD, Lant AF. J Hum Hypertens. 1995 Aug;9(8):687-9. PMID: 8523392 [PubMed - indexed for MEDLINE] Related citations 283. Association of angiotensin converting enzyme DD genotype with hypertension in diabetes. Wierzbicki AS, Nimmo L, Feher MD, Cox A, Foxton J, Lant AF. J Hum Hypertens. 1995 Aug;9(8):671-3. PMID: 8523387 [PubMed - indexed for MEDLINE] Related citations 284. Strategies for reducing coronary risk factors in primary care. Wierzbicki AS, Reynolds TM. BMJ. 1995 Jul 22;311(6999):263. No abstract available. PMID: 7627073 [PubMed - indexed for MEDLINE] Free PMC Article Related citations 285. Health promotion in general practice. Any beneficial effect was lost in background statistical noise. Wierzbicki AS, Reynolds TM. BMJ. 1995 Feb 25;310(6978):532-3. No abstract available. PMID: 7772130 [PubMed - indexed for MEDLINE] Free PMC Article Related citations 286. Glycated haemoglobin values. Methodological discrepancies are not important. Wierzbicki AS, Bickel M, Reynolds TM. BMJ. 1994 Dec 3;309(6967):1511. No abstract available. PMID: 7804063 [PubMed - indexed for MEDLINE] Free PMC Article Related citations 287. Screening for secondary causes of hyperlipidaemia in general practice. Correct diagnosis needs to be established. Reynolds TM, Wierzbicki AS, Feher MD. BMJ. 1994 Nov 19;309(6965):1373-4; author reply 1374-5. No abstract available. PMID: 7866105 [PubMed - indexed for MEDLINE] Free PMC Article Related citations 288. Maternal serum free beta hCG screening: results of studies including 480 cases of Down syndrome--problems with this approach.

34 of 37 Wierzbicki AS. Prenat Diagn. 1994 Nov;14(11):1093; author reply 1094-5. No abstract available. PMID: 7533287 [PubMed - indexed for MEDLINE] Related citations 289. Drug treatment of hypercholesterolaemia. Establish diagnosis before treatment. Feher MD, Wierzbicki AS, Reynolds TM. BMJ. 1994 Jan 1;308(6920):56-7. No abstract available. PMID: 8298359 [PubMed - indexed for MEDLINE] Free PMC Article Related citations 290. Tissue-specific expression of putative domains of the mouse neuronal alpha-2 and delta genes of the voltage-gated calcium channel in rodent tissues. Wierzbicki AS, Beeson DM, Lang B, Newsom-Davis J. Ann N Y Acad Sci. 1993 Dec 20;707:472-5. No abstract available. PMID: 9137598 [PubMed - indexed for MEDLINE] Related citations 291. Copper-64 metabolism in two patients with non-Wilsonian movement disorders and copper deficiency. Wierzbicki AS, Patel N, Evans K, Lascelles PT. J Neurol Sci. 1993 Oct;119(1):85-90. PMID: 8246016 [PubMed - indexed for MEDLINE] Related citations 292. Hairy leukaemic cell influx into the cerebrospinal fluid secondary to encephalomyelitis. Wierzbicki AS, Luxton R, McLean BN, Gilois C, Norman PM, Thompson EJ. Postgrad Med J. 1993 Aug;69(814):651-3. PMID: 8234115 [PubMed - indexed for MEDLINE] Free PMC Article Related citations 293. The tissue distribution of alpha 2-delta subunit genes of the voltage-gated calcium channel in rodent tissues and NG108-15 cells. Wierzbicki AS, Beeson DM, Lang B, Newsom-Davis J. Ann N Y Acad Sci. 1993 Jun 21;681:422-4. No abstract available. PMID: 8395160 [PubMed - indexed for MEDLINE] Related citations 294. Antibodies to L-type calcium channels in amyotrophic lateral sclerosis. Wierzbicki AS. N Engl J Med. 1993 May 6;328(18):1355-6; author reply 1356-7. No abstract available. PMID: 8385743 [PubMed - indexed for MEDLINE] Free Article Related citations 295. Molecular biology techniques. Wierzbicki AS. Ann Clin Biochem. 1993 May;30 ( Pt 3):332-4. No abstract available. PMID: 8517621 [PubMed - indexed for MEDLINE] Related citations 296. Bedside measurement of cardiac enzymes. Wierzbicki AS. Lancet. 1993 Apr 3;341(8849):890; author reply 890-1. No abstract available. PMID: 8096583 [PubMed - indexed for MEDLINE] Related citations

35 of 37 297. Paget's disease of bone. Wierzbicki AS. BMJ. 1993 Jan 30;306(6873):333. No abstract available. PMID: 8507262 [PubMed - indexed for MEDLINE] Free PMC Article Related citations 298. The hematological and electrophysiological effects of cobalamin. Deficiency secondary to vegetarian diets. Gilois C, Wierzbicki AS, Hirani N, Norman PM, Jones SJ, Ponsford S, Alani SM, Kriss A. Ann N Y Acad Sci. 1992 Sep 30;669:345-8. No abstract available. PMID: 1444044 [PubMed - indexed for MEDLINE] Related citations 299. POEMS syndrome: further investigations of an unusual case. Wierzbicki AS. Br J Hosp Med. 1991 Jul;46(1):18. No abstract available. PMID: 1868304 [PubMed - indexed for MEDLINE] Related citations 300. Cerebral neoplastic angioendotheleosis complicated by hypercalcaemia. Wierzbicki AS, Gibbs JM, Lidov HG, Lolin Y, Thomas PK. Postgrad Med J. 1991 Jun;67(788):571-3. PMID: 1924030 [PubMed - indexed for MEDLINE] Free PMC Article Related citations 301. Immunocytological diagnosis of primary cerebral non-Hodgkin's lymphoma. Lai AP, Wierzbicki AS, Norman PM. J Clin Pathol. 1991 Mar;44(3):251-3. PMID: 2013629 [PubMed - indexed for MEDLINE] Free PMC Article Related citations 302. Effect of haemolysate preparation on measurement of red cell folate by a radioisotopic method. Gilois CR, Stone J, Lai AP, Wierzbicki AS. J Clin Pathol. 1990 Feb;43(2):160-2. PMID: 2108191 [PubMed - indexed for MEDLINE] Free PMC Article Related citations 303. Antiepileptic drugs, hepatic enzyme induction and raised serum alkaline phosphatase isoenzymes. Nijhawan R, Wierzbicki AS, Tozer R, Lascelles PT, Patsalos PN. Int J Clin Pharmacol Res. 1990;10(6):319-23. PMID: 1983078 [PubMed - indexed for MEDLINE] Related citations 304. Transient nephrotic syndrome after anaesthesia resulting from a familial cryofibrinogen precipitating at 35 degrees C. Lolin Y, Razis PA, O'Gorman P, Hjelm M, Wierzbicki AS. J Med Genet. 1989 Oct;26(10):631-6. PMID: 2585459 [PubMed - indexed for MEDLINE] Free PMC Article Related citations 305. Cerebral nocardiosis in immunosuppressed patients: five cases. Barnicoat MJ, Wierzbicki AS, Norman PM. Q J Med. 1989 Aug;72(268):689-98. PMID: 2602552 [PubMed - indexed for MEDLINE] Related citations

36 of 37 306. Autoimmunity: a risk factor for allosensitization to blood products? Wierzbicki AS, Cousins DM. BMJ. 1989 Apr 8;298(6678):963. No abstract available. PMID: 2497879 [PubMed - indexed for MEDLINE] Free PMC Article Related citations 307. Autoimmunity: a risk factor for allosensitisation to blood products? Wierzbicki AS, Cousins DM. BMJ. 1989 Jan 14;298(6666):95-6. No abstract available. PMID: 2493308 [PubMed - indexed for MEDLINE] Free PMC Article Related citations 308. Screening for inherited metabolic diseases in adults with neurological disease. Wierzbicki AS, Tozer RG, Lolin Y, Lascelles PT, Thomas S, Hjelm M. Lancet. 1988 May 14;1(8594):1101. No abstract available. PMID: 2896923 [PubMed - indexed for MEDLINE]

37 of 37